SYNCOM ACQUIRES EXCLUSIVE DISTIBUTION RIGHTS TO NOVANAILRX, A FUNGICIDAL NAIL POLISH IN TEN (10) POPULAR COLORS INCLUDING CLEAR
Syncom Acquires Exclusive Distibution Rights To NovaNailRx, A Fungicidal Nail Polish In Ten (10) Popular Colors Including Clear
August 01, 2008 - Fairfield, NJ: Syncom Pharmaceuticals, a leading provider of contract sales services for drug developers, manufacturers and marketers - recently acquired exclusive distribution rights to NovaNailRx from Hathor Enterprises, Inc., Woodlands, TX
NovaNailRx is a fungicidal nail polish which treats while it hides unsightly nails. There are ten (10) colors available in conveniently packaged bottles. NovaNailRx is currently sold only to physicians through the Syncom web site, www.syncom.net. It is not available through local nail salons or pharmacies.
NovaNailRx can also be used as a preventative measure after treatment or to protect against developing nail fungus. NovaNailRx is compatible with oral medications used in the treatment of advanced stages of nail fungus. Over 35 million Americans are affected with nail fungus.
For further additional information about NovaNailRx, visit http://www.hathorrx.com or call 1-800-400-0056, extension 1100.
About Syncom Pharmaceuticals:
Syncom Pharmaceuticals is a leading contract-sales service provider that delivers tailor-made business solutions to pharmaceutical and medical-device developers. Leveraging a highly-experienced, carefully-selected team of sales representatives dispersed throughout the United States, Syncom offers flexible, customer-driven outsourcing solutions that compliment and enhance existing in-house sales initiatives. With more than twenty years of contract-sales experience, Syncom has successfully delivered business services to a vast number of Pharmaceutical organizations – from emerging drug developers to Fortune100 Companies. Syncom’s suite of scalable outsourcing solutions enables clients to increase and intensify sales coverage throughout the US without raising fixed capital costs. Syncom solutions allow drug developers to aggressively launch new therapeutic products, expand market reach to new geographic locations and maximize existing market share - without fear of over-employment or underselling. www.syncom.net
Syncom Pharmaceuticals, Inc.
6 Gloria Lane
Fairfield, NJ 07004-3306
Telephone: 1(973) 787-2405
